comorbidities and risk of drug–drug interactions. The fourth line of treatment for patients with resistant hypertension should include mineralocorticoid receptor antagonists such as spironolactone, as ...

Objectives This study aimed to summarise the current evidence from randomised control trials (RCTs) concerning treatment of patients with resistant hypertension with Chinese herbal medicine (CHM).

Why Choose Johns Hopkins to Treat Resistant Hypertension? Our center provides specialized treatment for complex high blood pressure disorders for all patients. Learn more about what makes our center ...

phc.ox.ac.uk To understand the definition, prevalence and prognosis of resistant hypertension. To describe the methods for effective diagnosis of resistant hypertension. To review the treatment ...

Aldosterone antagonists represent a well-established pharmacological tool for managing patients with resistant hypertension, even when true hyperaldosteronism is difficult to identify clinically ...

Idorsia Pharmaceuticals has claimed FDA approval for aprocitentan as a treatment for resistant hypertension, becoming the first drug in the endothelin receptor antagonist class for that indication.

Other recent outcome studies document that resistant hypertension is not rare. In the Controlled ONset Verapamil INvestigation of Cardiovascular End Points trial (CONVINCE), [2] more than 16,600 ...

Could Blood Pressure Medication Increase Your Wet AMD Risk? Could the medication you take for hypertension be affecting ... Find out what the top and the bottom blood pressure numbers mean ...

Our multidisciplinary team includes physicians from the Divisions of Cardiology, Endocrinology, Diabetes and Metabolism, and Nephrology and General Medicine ... can be referred for treatment for ...

ACC's free online course, Overcoming Challenges in Hypertension Management, is self-paced learning to equip clinicians with best practices ... and the newly approved drug aprocitentan, an endothelin ...